Clinical Trial Update: Canadian Avonex PEN Productivity Study

View source ↗

Summary

This clinical trial update reports the completion of a Canadian study evaluating the Avonex PEN productivity in people with multiple sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Avonex PEN (interferon beta-1a)

Snippet

Sponsor: Biogen | Conditions: Multiple Sclerosis | Status: COMPLETED